MedTrace Logo

Promoting Influenza Vaccination In General Practice Waiting Rooms

NCT03239795 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10597

Last updated 2017-08-04

No results posted yet for this study

Summary

Most of family physicians (FPs) use advertising in their waiting rooms in order to educate patients. Our objective was to assess an advertising campaign for influenza vaccination using posters and pamphlets in FPs' waiting rooms.

Registry based 2/1 cluster randomized controlled trial. Clusters gathered the listed patients over the age of 16 of 75 randomized FPs. The trial was conducted during the 2014-2015 influenza vaccination campaign. Intervention group, 25 FPs received and exposed in their waiting rooms pamphlets and one poster promoting the influenza vaccination campaign (added to the usual mandatory information). Control group (50 FPs), usual waiting room. The main outcome was the number of vaccination units delivered in pharmacies. Data were first extracted for 2013-2015 from the SIAM-ERASME claim database of the Health Insurance Fund of Lille-Douai (Northern France). The association between the intervention and the main outcome was assessed trough a generalized estimating equation.

Conditions

  • Health Behavior
  • Vaccination
  • Influenza, Human

Interventions

OTHER

Advertisement

Advertisement by means of a poster and pamphlets in FP waiting rooms, removing all the other posters and pamphlets (except mandatory information, like opening hours, fees, etc.)

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Christophe Berkhout

    lead INDIV

Principal Investigators

  • Christophe Berkhout, MD · Lille Univ. UDSL

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-15
Primary Completion
2015-02-28
Completion
2017-05-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03239795 on ClinicalTrials.gov